When it comes to the $24 billion outsourced drug development industry, North Carolina is the undisputed – and still undefeated – heavyweight champion of the world. It's home to 128 contract research organizations employing over 21,000 people within the state and tens of thousands of others around the world.
News from BIO 2015
North Carolina has substantial university and company assets devoted to health informatics, a quickly evolving SuperScieNCe field that uses databases, electronic medical records, bioinformatics and other tools to support clinical decisions that improve health care efficiency, delivery and outcomes.
Delivering precise treatments customized for each person’s unique genetic makeup is the powerful promise of personalized medicine, and North Carolina is already a leader in this new era of genomics-based health care.
Companies and university researchers across North Carolina are harnessing compounds, microorganisms and unique materials to bring advanced wound healing, surgical devices and regenerative medicine to civilian and military markets.
North Carolina is one of the world’s leading centers for the manufacture of biologics, pharmaceuticals, vaccines, diagnostics, medical devices and related products.